Narek Shaverdian
Memorial Sloan Kettering Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Narek Shaverdian as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:43 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07594522 · A Study of Ivonescimab in People With Non-Small Cell Lung CancerMemorial Sloan Kettering Cancer Center · recruiting · Non-Small Cell Lung Cancer · principal investigator
- Ph2NCT07323732 · A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung DiseaseMemorial Sloan Kettering Cancer Center · recruiting · NSCLC, NSCLC, Stage I, NSCLC Stage II · principal investigator
- Ph2NCT06333678 · A Study Comparing Sotorasib With Durvalumab in People With Non-Small Cell Lung Cancer (NSCLC)Memorial Sloan Kettering Cancer Center · terminated · Non-Small Cell Lung Cancer · principal investigator
- Ph2NCT04905316 · A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung CancerMemorial Sloan Kettering Cancer Center · completed · Non-small Cell Lung Cancer · principal investigator
- Ph2NCT03999710 · Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung CancerMemorial Sloan Kettering Cancer Center · completed · Non Small Cell Lung Cancer, Lung Cancer, Nsclc · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:43 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:43 UTC. The ranking covers the 200 most relevant of 12 PubMed records, and a shared surname and initials can bring in a namesake. All 12 on PubMed
- 910 citationsRCR 28.9
- 270 citationsRCR 30.0
- Potential Impact of 68Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer.J Nucl Med · 2018101 citationsRCR 4.1
- Treatment-Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single Center.Cancer Immunol Res · 201885 citationsRCR 2.8
- Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis.Int J Radiat Oncol Biol Phys · 202333 citationsRCR 4.4
- 26 citationsRCR 1.0
- Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer.Int J Radiat Oncol Biol Phys · 202322 citationsRCR 1.7
- Functional Outcomes After De-escalated Chemoradiation Therapy for Human Papillomavirus-Positive Oropharyngeal Cancer: Secondary Analysis of a Phase 2 Trial.Int J Radiat Oncol Biol Phys · 201811 citationsRCR 0.5
- 10 citationsRCR 0.5
- Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation Trial.Int J Radiat Oncol Biol Phys · 20247 citationsRCR 0.4